Twelve-lead electrocardiograms (ECGs) are one of the most frequent ways to assess cardiac health and are available in many clinics or hospitals. However, these require the patient to be on-site or for a physician to be present when using the device. This means that only palpitations that occur during medical visits are caught, and those that occur in between visits are missed.
The CardiacSense watch uses both a one-lead ECG (measuring electrical signals in the heart) and a photoplethysmography (PPG) sensor (measuring the rate of blood flow through light-based technology) to give a comprehensive overview of a patient’s cardiac health. This medical device is worn like a smartwatch and can be worn by the patient going about their daily lives. When compared to an FDA-approved ECG Holter, the CardiacSense watch showed a sensitivity rate of no less than 96%3 . Classic smartwatches that provide heart monitoring services rely on intermittent measurements rather than continuous ones, so there are large gaps in the data they provide4.
In case of deterioration of the patient’s health, the healthcare provider will be alerted, and the patient can be called for consultation. In addition, once the patient does see a specialist or physician, they will have a wealth of intermediate recorded data to inform the healthcare practitioner’s decisions.
 Antonio Raviele and others, Management of patients with palpitations: a position paper from the European Heart Rhythm Association, EP Europace, Volume 13, Issue 7, July 2011, Pages 920–934, https://doi.org/10.1093/europace/eur130
 Goyal A, Robinson KJ, Katta S, et al. Palpitation. [Updated 2023 Apr 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK436016/
CardiacSense, ECG Evaluation Report, A Prospective Study for Evaluating the Safety and Performance Of CSF-3 ECG Lead-I, HR and PR When Compared to ECG Holter, 2022
 CardiacSense, A Prospective, Open, Multi-Center, Controlled Study to Evaluate the Safety, Performance and Efficacy of the CardiacSense1 for Detection of Atrial Fibrillation, 2020